Literature DB >> 29800980

Cost-effectiveness of Nusinersen for Spinal Muscular Atrophy-Reply.

Vinay Prasad1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29800980     DOI： 10.1001/jamapediatrics.2018.0733

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN： 2168-6203            Impact factor:   16.193


× No keyword cloud information.
  1 in total

1.  Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy.

Authors:  Ali Jalali; Erin Rothwell; Jeffrey R Botkin; Rebecca A Anderson; Russell J Butterfield; Richard E Nelson
Journal:  J Pediatr       Date:  2020-07-11       Impact factor: 4.406
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.